Article
Risk of having BRCA1 mutation in high-risk women with triple-negative breast cancer: a meta-analysis.
Clinical genetics - 1 Jan 2014
Tun N M, Villani G, Ong K, Yoe L, Bo Z M
Abstract excerpt
Testing for BRCA1 mutation has important clinical implications such as identifying risk of second primary cancers and risk of cancer in the family. This study seeks to quantify the risk of having BRCA1 mutation in female breast cancer patients with triple-negative phenotype compared with those with other phenotypes. We undertook a search of MEDLINE and EMBASE databases for relevant studies through 10 May 2013....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
